Treatment Indications: correction of deep facial wrinkles and folds (including nasolabial folds, marionette lines, glabellar lines),, volumetric restoration of deep facial compartments (midface, cheeks, chin),, correction of severe tissue depression and age‑related volume loss,, architectural facial modeling requiring high‑density support
Release form: 1 × 1.1 mL pre‑filled syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation), lidocaine hydrochloride, phosphate‑buffered saline solution; includes a cooling component to reduce injection discomfort during deep placement
Concentration of GC: 20 mg/mL
Lidocaine: 0.3%
Indications: deep dermal to subdermal volumization, structural contouring requiring a high‑density,, cohesive gel with elevated storage modulus (G’) for stable,, long‑lasting results; correction of pronounced facial atrophy,, sharp contour definition, and 3D facial reshaping where maximal support and minimal gel migration are critical